IRIS
CIPRIANI, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.031
EU - Europa 5.247
AS - Asia 3.907
SA - Sud America 342
AF - Africa 30
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 15
Totale 17.593
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.988
IE - Irlanda 1.626
SG - Singapore 1.351
CN - Cina 1.103
TR - Turchia 685
RU - Federazione Russa 675
HK - Hong Kong 619
IT - Italia 606
SE - Svezia 590
DE - Germania 494
UA - Ucraina 401
BR - Brasile 309
GB - Regno Unito 309
FI - Finlandia 206
FR - Francia 175
IN - India 51
BE - Belgio 46
VN - Vietnam 34
NL - Olanda 31
CA - Canada 28
CZ - Repubblica Ceca 21
AU - Australia 14
EU - Europa 14
AR - Argentina 9
ZA - Sudafrica 9
AT - Austria 8
EC - Ecuador 8
LT - Lituania 8
MX - Messico 8
GR - Grecia 7
NZ - Nuova Zelanda 7
DZ - Algeria 6
ES - Italia 6
MA - Marocco 6
UZ - Uzbekistan 6
CH - Svizzera 5
CO - Colombia 5
IQ - Iraq 5
MK - Macedonia 5
PK - Pakistan 5
AL - Albania 4
AZ - Azerbaigian 4
BD - Bangladesh 4
ID - Indonesia 4
JO - Giordania 4
RO - Romania 4
VE - Venezuela 4
DK - Danimarca 3
GE - Georgia 3
HU - Ungheria 3
JP - Giappone 3
KR - Corea 3
KZ - Kazakistan 3
LU - Lussemburgo 3
NP - Nepal 3
PY - Paraguay 3
TN - Tunisia 3
BG - Bulgaria 2
IL - Israele 2
IR - Iran 2
JM - Giamaica 2
LB - Libano 2
NO - Norvegia 2
PE - Perù 2
PH - Filippine 2
PT - Portogallo 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
CG - Congo 1
CI - Costa d'Avorio 1
CL - Cile 1
DO - Repubblica Dominicana 1
EG - Egitto 1
HN - Honduras 1
KE - Kenya 1
KG - Kirghizistan 1
KW - Kuwait 1
LK - Sri Lanka 1
MD - Moldavia 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
NG - Nigeria 1
PA - Panama 1
PL - Polonia 1
PR - Porto Rico 1
TH - Thailandia 1
TW - Taiwan 1
Totale 17.593
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.642
Dublin 1.620
Chandler 1.609
Singapore 656
Hong Kong 617
Boardman 577
Santa Clara 569
Izmir 403
Nanjing 273
New York 251
Wilmington 246
Lawrence 235
Princeton 235
San Mateo 225
Ann Arbor 196
Ashburn 167
Moscow 159
Beijing 130
L'aquila 129
Nanchang 100
Milan 97
Dearborn 85
Woodbridge 82
Seattle 70
Shenyang 65
Los Angeles 58
Helsinki 55
Des Moines 52
Verona 49
Kunming 46
Mountain View 43
Shanghai 43
Brussels 42
Hebei 42
L’Aquila 42
Jiaxing 41
Jinan 35
Dong Ket 34
Tianjin 33
Changsha 31
Zhengzhou 29
Dallas 28
Norwalk 27
Rome 27
The Dalles 27
Hefei 24
Pune 23
Munich 22
Philadelphia 22
São Paulo 21
Pescara 20
Hangzhou 19
Brno 18
Council Bluffs 18
Guangzhou 18
Ningbo 18
Frankfurt am Main 16
Falkenstein 15
Kitzingen 15
Houston 14
Lanzhou 11
Rio de Janeiro 11
Bremen 10
Cedar Knolls 10
Redwood City 10
Changchun 9
Taizhou 9
Washington 9
Amsterdam 8
Auburn Hills 8
Falls Church 8
Grafing 8
Belo Horizonte 7
Brasília 7
Edinburgh 7
Fremont 7
Lappeenranta 7
Phoenix 7
Jinhua 6
Ottawa 6
Quito 6
Reggio Nell'emilia 6
Stockholm 6
Tashkent 6
Bari 5
Berlin 5
Düsseldorf 5
Guarulhos 5
Johannesburg 5
London 5
New Delhi 5
Toronto 5
Amman 4
Assago 4
Auckland 4
Brisbane 4
Campinas 4
Fortaleza 4
Fuzhou 4
La Spezia 4
Totale 11.766
Salva come PNG Salva come JPEG
Nome #
Aumento dei linfociti circolanti gamma-delta Vdelta1+ in corso di malattie infiammatorie intestinali 139
Studio dell’espressione della chemochina SDF-1 e del suo recettore CXCR4 nella cute e nelle cellule endoteliali microvascolari di pazienti affetti da sclerosi sistemica (SSc). 131
Perivascular cells in diffuse cutaneous systemic sclerosis overexpress activated ADAM12 and are involved in myofibroblast transdifferentiation and development of fibrosis 129
Role of CD248 molecule as potential regulator of trans-differentiation toward myofibroblasts of perivascular stromal cells in systemic sclerosis patients 116
The CD68+/H-ferritin+ cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: Correlation with disease severity and implication for pathogenesis 115
Prognostic factors of adult onset Still’s disease: analysis of 100 cases in 3 tertiary referral centers 113
FRI0613 H-ferritin and pro-inflammatory cytokines are increased in the bone marrow of adult patients affected by macrophage activation syndrome 113
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 108
The emerging role of IL-1 inhibition in patients affected by rheumatoid arthritis and diabetes 107
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 106
association of pathogenic and regulatory B-cell subsets with clinical and histological features in primary Sjogren's syndrome. 106
Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts 104
The role of extracellular matrix components in angiogenesis and fibrosis: Possible implication for Systemic Sclerosis. 104
Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients. 104
H-ferritin and CD68(+) /H-ferritin(+) monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease 104
Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 103
Where are we going in the management of interstitial lung disease in patients with systemic sclerosis? 103
Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers 102
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 97
Association between a stromal cell-derived factor 1 (SDF-1/CXCL12) gene polymorphism and microvascular disease in systemic sclerosis 96
Linfociti T Gamma-Delta (G/D) in pazienti con malattie infiammatorie intestinali (IBD) 96
PTP4A1 promotes TGFβ signaling and fibrosis in systemic sclerosis 96
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 96
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 93
Stromal Cell-derived Factor 1 in Cardiac and Autoimmune Disease 92
Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy. 92
Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients. 91
Cardiovascular disease in primary sjögren’s syndrome 91
Efficacy of inhibition of IL-1 in patients with rheumatoid arthritis and type 2 diabetes mellitus: two case reports and review of the literature. 90
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 90
Stem cell therapies for systemic sclerosis 89
Interleukin (IL)-22 receptor 1 is over-expressed in primary Sjogren's syndrome and Sjögren-associated non-Hodgkin lymphomas and is regulated by IL-18. 89
Combined approach to the initial stage raynaud’s phenomenon diagnosis by means of dynamic digital telehermograpy, capillaroscopy and pletismography. Preliminary findings. 88
Comment on 'Where are we going in the management of interstitial lung disease in patients with systemic sclerosis?' 87
EFFICACY AND SAFETY OF RITUXIMAB TREATMENT IN EARLY PRIMARY SJOGREN'S SYNDROME: A CLINICAL, HISTOLOGICAL AND MOLECULAR STUDY 87
Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis 87
Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies. 87
Increased cardiovascular events and subclinical atherosclerosis in rheumatoid arthritis patients: 1 year prospective single centre study 86
T Regulatory and T Helper 17 Cells in Primary Sjögren's Syndrome: Facts and Perspectives. 86
Impaired Cav-1 expression in SSc mesenchymal cells upregulates VEGF signaling: a link between vascular involvement and fibrosis 85
IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone? 85
Interleukin-9 Overexpression and Th9 Polarization Characterize the Inflamed Gut, the Synovial Tissue, and the Peripheral Blood of Patients With Psoriatic Arthritis 85
GAMMA/DELTA T CELL APOPTOSIS IN SYSTEMIC SCLEROSIS PATIENTS 85
Searching for a good model for systemic sclerosis: The molecular profile and vascular changes occurring in UCD-200 chickens strongly resemble the early phase of human systemic sclerosis 85
Methotrexate in rheumatoid arthritis: optimizing therapy among different formulations. Current and emerging paradigms 84
Impaired Endothelium-Mesenchymal Stem Cells Cross-talk in Systemic Sclerosis: a Link Between Vascular and Fibrotic Features. 84
Circulating gamma/delta T lymphocytes from systemic sclerosis (SSc) patients display a T helper (Th) 1 polarization 83
Peripheral blood mononuclear cells of patients with systemic sclerosis produce increased amounts of interleukin 6, but not transforming growth factor beta 1. 83
SENESCENT BONE MARROW DERIVED MESENCHYMAL STEM CELLS (MSC) ARE PRONE TO RECOVER DURING SSC 82
Different operators and histologic techniques in the assessment of germinal center-like structures in primary Sjögren's syndrome minor salivary glands 82
Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease. 81
EFFETTI DEI CAMPI ELETTROMAGNETICI LENTAMENTE VARIABILI SU SPERMATOZOI UMANI. VII CONGRESSO AIBG, ASSOCIA-ZIONE ITALIANA DI BIOLOGIA E GENETICA GENERALE E MOLECOLARE 81
The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis. 81
SAT0489 Biologic Therapies and Infections in The Daily Practice: A Study on Historical Cohort from 3 Italian Rheumatologic Units 81
Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis: Results from a cross-sectional study. 81
Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study. 81
Unmasking the pathogenic role of il-17 axis in primary sj¨ogren’s syndrome: A new era for therapeutic targeting? 81
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis. 81
DUO Registry Group. Functional impairment of systemic scleroderma patients with digital ulcerations: results from the DUO Registry. 80
Association of psoriasis and/or psoriatic arthritis with autoimmune diseases: the experience of two Italian integrated Dermatology/Rheumatology outpatient clinics. 79
Combined approach to the initial stage raynaud's phenomenon diagnosis by means of dynamic digital telethermography, capillaroscopy and pletismography preliminary findings. 79
SDF-1/CXCR4 system in microvascular endothelial cells and skin from patients affected by systemic sclerosi 79
Interstitial lung disease in systemic sclerosis: current and future treatment. 79
Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers.. Epub 2002 Aug 30 78
Pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance identifies a very early cardiac involvement in systemic sclerosis patients of recent onset 78
Gamma-delta T cells are not involved in the natural and antibody-dependent cytotoxicity of peripheral blood mononuclear cells in inflammatory bowel disease. 78
The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist. 78
Decreased Expression of Angiopoetin 1 on Perivascular Mesenchymal Stem Cells from Ssc Patients Induces an Anti Angiogenetic Effect, when Co-cultured with Endothelial Cells 77
FAS -670 gene promoter polymorphism confers susceptibility to systemic sclerosis 77
Endothelial progenitor cells: Are they displaying a function in autoimmune disorders? 77
Interleukin (IL)-17-producing pathogenic T lymphocytes co-express CD20 and are depleted by rituximab in primary Sjögren's syndrome: A pilot study 77
Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort 77
Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implications 76
High levels of NK cells in the peripheral blood of patients affected with anti-phospholipid syndrome and recurrent spontaneous abortion: a potential new hypothesis 76
The Role of IL-1β in the Bone Loss during Rheumatic Diseases 76
Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS. 76
Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations 76
Evaluating the multivisceral involvement on adult-onset Still’s disease to retrieve imaging-based differences in patients with and without macrophage activation syndrome: results from a single-centre observational study 76
Stem cells in autoimmune diseases: Implications for pathogenesis and future trends in therapy. 75
CD4(-)CD8(-) T-cells in primary Sjögren's syndrome: association with the extent of glandular involvement. 75
The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis 75
Myositis in primary Sjögren's syndrome: data from a multicentre cohort. 74
Serum levels of soluble CD30 are increased in ulcerative colitis (UC) but not in Crohn's disease (CD). 74
Combination therapy with cyclosporine and methotrexate in patients with earlyrheumatoid arthritis soon inhibits TNFa production without . decreasing TNFa mRNA levels. An in vivo and in vitro stufy 74
Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis 74
Increase of circulating gamma/delta T lymphocytes in the peripheral blood of patients affected by active inflammatory bowel disease 74
SDF-1 expression in the skin of SSc patients. 74
A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjögren's syndrome 74
Surface expression of fractalkine receptor (CX3CR1) on CD4+/CD28-. T cells in RA patients and correlation with atherosclerotic damage 74
Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers. 74
 T cells in placenta and skin: their different functions may support the paradigm of microchimerism in systemic sclerosi 73
LONG-TERM ANTI-TNF THERAPY AND RISK OF SERIOUS INFECTIONS IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS: COMPARISON AMONG ADALIMUMAB, ETANERCEPT AND INFLIXIMAB. ANNALS OF THE RHEUMATIC DISEASES 73
IL-6 production from peripheral blood mononuclear cells (PBMC) of patients affected by progressive systemic sclerosis (PSS). 73
Interleukin (IL)-9/IL-9R axis drives γδ T cells activation in psoriatic arthritis patients 73
Computed Tomography and MR Imaging in Rheumatoid Arthritis 73
Macrophage activation syndrome in patients affected by adult-onset still disease: Analysis of survival rates and predictive factors in the Gruppo Italiano di Ricerca in reumatologia clinica e sperimentale cohort 73
Myofibroblast Cells Expression of CD248 May Contribute to Exacerbate Microvascular Damage during Systemic Sclerosis 73
Combination therapy with cyclosporine and methotrexate in patients with early rheumatoid arthritis soon inhibits TNFalpha production without decreasing TNFalpha mRNA levels. An in vivo and in vitro study 73
Variations of neuronal nitric oxide synthase in systemic sclerosis skin 72
Immunopatogenesi della sclerosi sistemica. 72
Totale 8.652
Salva come PNG Salva come JPEG
Categoria #
all - tutte 87.799
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.799
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020295 0 0 0 0 0 0 0 0 0 0 21 274
2020/20211.915 37 225 21 243 245 86 254 20 236 73 371 104
2021/20221.310 74 88 249 96 33 19 28 63 108 68 93 391
2022/20234.607 336 251 82 479 395 489 31 298 2.013 30 143 60
2023/20241.248 168 74 82 157 106 363 25 73 9 57 36 98
2024/20254.445 114 89 484 180 650 461 673 394 1.179 213 8 0
Totale 17.933